Literature DB >> 33547483

SARS-COV-2 transmission rate is low when following a COVID+ patient in the operating room.

Lucas G Axiotakis1, Deborah M Boyett2, Brett E Youngerman2, Guy M McKhann2, Anil K Lalwani3,4.   

Abstract

PURPOSE: Acquiring SARS-CoV-2 infection for uninfected patients undergoing surgical procedures following a COVID positive (COVID+) patient is of significant concern, both for patients seeking medical care in hospital settings and for management of surgical services during pandemic times.
METHODS: Using data identifying all COVID+ surgical patients during the initial pandemic peak in New York City (March 15 to May 15, 2020), we analyzed the rate of postoperative symptomatic SARS-CoV-2 infection in COVID negative (COVID-) patients undergoing surgery in the same operating room within 48 h, thus determining nosocomial symptomatic infection rate attributable to COVID operating room exposure.
RESULTS: Five COVID- patients directly followed a COVID+ patient, while 19 patients were exposed to COVID+ operating rooms within 24 h. By 48 h, 21 additional patients were exposed. No exposed patients acquired symptomatic SARS-CoV-2 infection postoperatively.
CONCLUSION: With implementation of infection prevention and control procedures in the operating room under local pandemic conditions, our findings suggest that the risk of acquiring SARS-CoV-2 infection, when following a COVID+ patient in the same operating room, is very low.

Entities:  

Keywords:  COVID-19 pandemic; Nosocomial infection; Patient safety; Perioperative services

Mesh:

Year:  2021        PMID: 33547483      PMCID: PMC7864797          DOI: 10.1007/s00423-021-02085-0

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   2.895


Introduction

During the current global coronavirus disease 2019 (COVID-19) pandemic, acquiring SARS-CoV-2 infection in the hospital is of significant concern for patients needing acute care. In the operating room (OR), aerosolized SARS-CoV-2 particles and those surviving on surfaces for extended periods (>48 h) are worrisome for nosocomial transmission [1-3]. This is particularly concerning for COVID negative (COVID−) patients undergoing invasive surgical procedures immediately following COVID positive (COVID+) patients in the same OR. To minimize risk of SARS-CoV-2 transmission between surgical cases during the pandemic, hospitals have implemented infection prevention and control procedures specific to the OR environment, including designating COVID ORs, instituting routine “terminal” cleaning of the OR (i.e., protocols normally performed at the end of the day including disinfecting all vertical and horizontal surfaces, equipment, and receptacles), delaying entry to the room by 30-minutes to effect >99.9% air turnover, and placing viral filters in the expiratory limb of the circuit and between the breathing circuit and the patient’s airway to prevent transmission via ventilators. Despite these measures, their effectiveness in preventing transmission due to OR exposure is unclear. Herein, we investigate the risk of acquiring perioperative SARS-CoV-2 infection when a COVID− patient follows a COVID+ patient in the same OR.

Materials and methods

All index surgeries occurring at Columbia University during the initial peak of the COVID-19 pandemic, from March 15 to May 15, 2020, were analyzed. Preoperatively and postoperatively, patients were considered COVID+ if they tested positive or had 2+ of 7 symptoms based on Centers for Disease Control (CDC) guidelines [4]. Exposure to SARS-CoV-2 was defined as surgery occurring after a COVID+ patient in the same OR up to 48 h postoperatively; therefore, a COVID− patient could undergo surgery in the same operating room as no COVID+ patients, one COVID+ patient, or greater than one COVID+ patient within this timeframe. “Exposure” for the COVID− patient was defined as the number of COVID+ cases conducted in the previous 48 h in the same OR. The Columbia University Institutional Review Board approved the collection of the data analyzed in this study.

Results

During the study time period, 552 analyzable patients (51 COVID+ and 501 COVID−) underwent surgery. Five COVID− patients (1.0%) directly followed a COVID+ case on the same day. Nineteen patients (3.8%) went on to follow a COVID+ case, resulting in 23 exposures, within 24 h (Table 1); none acquired symptomatic SARS-CoV-2 infection postoperatively. Twenty-one COVID− patients (4.2%) followed a COVID+ case within 24 and 48 h, resulting in 29 exposures; similarly, none acquired symptomatic SARS-CoV-2 infection postoperatively. Nine patients (1.8%) followed more than one COVID+ patient undergoing surgery in the same OR within the prior 48 h. During the same study period, 9 (of 456, or 1.9%) patients without COVID+ OR exposure acquired postoperative SARS-CoV-2 infection confirmed by PCR testing. Exposure to COVID+ ORs was not significantly associated with symptomatic perioperative SARS-CoV-2 infection (Fisher’s exact test, p = 1.00). Total weekly exposures of COVID− patients to COVID+ ORs correlated with average caseload and the number of ORs in use as the study period unfolded (Fig. 1).
Table 1

Nature of perioperative COVID exposures

COVID+ OR exposures*Testing status of COVID+ OR patient (N)**
Presumed positivePositive test 1–3 days preopPositive test >3 days preopTotal
Immediately following COVID+ case3025
Exposure within 24 h of COVID+ case721423
Exposure 24–48 h after COVID+ case1091029
Total20112657

Table 1 includes all individual instances of exposures to specific COVID+ ORs (n = 57). Number of patients exposed (n = 45) is not shown; this difference is accounted for by n = 9 patients who were exposed to COVID+ ORs on >1 occasion within 48 h

*Time elapsed between a COVID+ patient undergoing surgery followed by a COVID− in the same OR was stratified by (row 1) the next case in the COVID+ OR within the same day, (row 2) within 24 h but not directly following a COVID+ cases within the same day, and (row 3) within 24–48 h of a COVID+ case

**Preoperative COVID+ patients were stratified by (column 1) remote positive testing >3 days preoperatively; (column 2) positive test within 0 to 3 days preoperatively; (column 3) presumed infection based on 2+ of 7 CDC-defined symptoms without testing or with positive test on postoperative day 1 [4]

Fig. 1

COVID− surgical patients exposed to COVID+ ORs within 48 h, March 15–May 15. X-axis = study week (7 days each beginning on March 15). Week 9 consists of only 6 days due to the study period end date (ending on May 15). Left Y-axis (bars) = total number of exposures per week of COVID− patients to ORs in which a COVID+ patient had undergone surgery within 48 h. The key indicates screening status of COVID+ patients (presumed positive based on symptoms, or positive testing preoperatively) accounting for OR exposures. Right Y-axis (lines) = weekly averages of daily case counts (diamonds) and number of ORs in use (squares) during the study period, representing the initial peak of the pandemic at our tertiary hospital center

Nature of perioperative COVID exposures Table 1 includes all individual instances of exposures to specific COVID+ ORs (n = 57). Number of patients exposed (n = 45) is not shown; this difference is accounted for by n = 9 patients who were exposed to COVID+ ORs on >1 occasion within 48 h *Time elapsed between a COVID+ patient undergoing surgery followed by a COVID− in the same OR was stratified by (row 1) the next case in the COVID+ OR within the same day, (row 2) within 24 h but not directly following a COVID+ cases within the same day, and (row 3) within 24–48 h of a COVID+ case **Preoperative COVID+ patients were stratified by (column 1) remote positive testing >3 days preoperatively; (column 2) positive test within 0 to 3 days preoperatively; (column 3) presumed infection based on 2+ of 7 CDC-defined symptoms without testing or with positive test on postoperative day 1 [4] COVID− surgical patients exposed to COVID+ ORs within 48 h, March 15–May 15. X-axis = study week (7 days each beginning on March 15). Week 9 consists of only 6 days due to the study period end date (ending on May 15). Left Y-axis (bars) = total number of exposures per week of COVID− patients to ORs in which a COVID+ patient had undergone surgery within 48 h. The key indicates screening status of COVID+ patients (presumed positive based on symptoms, or positive testing preoperatively) accounting for OR exposures. Right Y-axis (lines) = weekly averages of daily case counts (diamonds) and number of ORs in use (squares) during the study period, representing the initial peak of the pandemic at our tertiary hospital center

Discussion

With continued increases in hospitalized COVID-19 patients throughout various areas of the USA, hospital-acquired SARS-CoV-2 infection remains a significant concern. In addition to OR-specific safety measures, surgical services have adopted a multitude of approaches aimed at reducing nosocomial infection, including but not limited to performing emergent procedures only, decreasing overall caseload and ORs in use, and instituting mandatory screening to inform triage and preoperative decision-making [5, 6]. Nonetheless, on occasion, when a COVID− patient follows in a room where a COVID+ patient underwent surgery, transmission concerns remain high. In this study, we show that, under these circumstances, the risk of symptomatic COVID infection is very low. Our finding suggests that the infection prevention and control procedures implemented within ORs have been effective in minimizing COVID transmission among surgical patients; this finding may help alleviate patient concerns of nosocomial SARS-CoV-2 infection, especially when inpatient and surgical care is necessary during the pandemic. Ostensibly, exposure to COVID of the small cohort of patients acquiring symptomatic infection perioperatively occurred in other areas of the hospital environment, or in the community at large. This study is limited by its retrospective nature and reliance on chart review for diagnosis, evolution of protocols during the study period, and inability to assess the COVID status of OR staff.

Conclusion

With thorough implementation of infection prevention and control procedures in the OR, our findings suggest that the risk of symptomatic infection following a COVID+ patient in the same OR is very low.
  5 in total

Review 1.  Global guidance for surgical care during the COVID-19 pandemic.

Authors: 
Journal:  Br J Surg       Date:  2020-04-15       Impact factor: 6.939

2.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

Authors:  Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster
Journal:  N Engl J Med       Date:  2020-03-17       Impact factor: 91.245

3.  Maximizing the Calm before the Storm: Tiered Surgical Response Plan for Novel Coronavirus (COVID-19).

Authors:  Samuel Wade Ross; Cynthia W Lauer; William S Miles; John M Green; A Britton Christmas; Addison K May; Brent D Matthews
Journal:  J Am Coll Surg       Date:  2020-03-30       Impact factor: 6.113

Review 4.  Sustainability of Coronavirus on Different Surfaces.

Authors:  Rajiv Suman; Mohd Javaid; Abid Haleem; Raju Vaishya; Shashi Bahl; Devaki Nandan
Journal:  J Clin Exp Hepatol       Date:  2020-05-06

5.  Electrocautery, Diathermy, and Surgical Energy Devices: Are Surgical Teams at Risk During the COVID-19 Pandemic?

Authors:  Kimberley Zakka; Simon Erridge; Swathikan Chidambaram; Michael Kynoch; James Kinross; Sanjay Purkayastha
Journal:  Ann Surg       Date:  2020-06-09       Impact factor: 12.969

  5 in total
  2 in total

Review 1.  Surveillance of omicron variants through wastewater epidemiology: Latest developments in environmental monitoring of pandemic.

Authors:  Vatika Soni; Shilpa Paital; Pankaj Raizada; Tansir Ahamad; Aftab Aslam Parwaz Khan; Sourbh Thakur; Pardeep Singh; Chaudhery Mustansar Hussain; Swati Sharma; Ashok Kumar Nadda
Journal:  Sci Total Environ       Date:  2022-06-15       Impact factor: 10.753

Review 2.  Patient, Surgeon, and Health Care Worker Safety during the COVID-19 Pandemic.

Authors:  Arnulf H Hölscher
Journal:  Ann Surg       Date:  2021-11-01       Impact factor: 13.787

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.